Literature DB >> 29392463

Insular multiple sclerosis lesions are associated with erectile dysfunction.

Klemens Winder1, Ralf A Linker1, Frank Seifert1, Martina Deutsch1, Tobias Engelhorn2, Arnd Dörfler2, De-Hyung Lee1, Katharina M Hösl3, Max J Hilz4.   

Abstract

Erectile function (EF) is frequently compromised in men with multiple sclerosis (MS). Functional neuroimaging in healthy men identified a network of brain areas, such as the insula, visual and somatosensory association areas, cingulate gyrus, prefrontal cortex, as well as subcortical regions, contributing to EF. This study intended to determine associations between EF deterioration during MS and cerebral MS-associated lesion sites. In 31 men with MS (mean age 38.2 ± 11.2 years), we evaluated MS-related EF deterioration by comparing scores of the 5-item International Index of Erectile Function-5 questionnaire (IIEF5) at the time of study and retrospectively, 3 months prior to MS diagnosis, by calculating score differences as DeltaIIEF5 (DeltaIIEF5 score < 0 indicated EF deterioration). To assess the impact of confounding factors of EF, patient age, disease duration, disease severity, depressiveness, bladder and bowel symptoms, and total cerebral MS lesion volume were correlated with DeltaIIEF5 scores (Spearman rank correlation) and compared between patients with and without EF deterioration (t tests or Mann-Whitney U test). MS lesions were assessed on T2-weighted magnetic resonance imaging (MRI; 1.5 or 3 T). We determined the lesion overlap (prevalence of identical lesion sites among patients), subtracted lesion overlaps in patients without EF deterioration from overlaps in patients with EF deterioration, and compared DeltaIIEF5 scores voxel-wise between patients with and without lesions in a given voxel (t test; significance: p < 0.05). In 14 patients (45.2%), DeltaIIEF5 scores indicated EF deterioration. DeltaIIEF5 scores were not associated with age (ρ = 0.06; p = 0.74), disease duration (ρ = 0.26; p = 0.15), disease severity (ρ = - 0.19; p = 0.31), depressiveness (ρ = 0.07; p = 0.72), bladder symptoms (ρ = - 0.11; p = 0.57), bowel symptoms (ρ = 0.17; p = 0.37), and total lesion volume (ρ = - 0.13; p = 0.47). The voxel-wise analysis showed associations between EF deterioration and MS lesions primarily in the bilateral, and predominantly left juxtacortical insular region. In conclusion, MS lesions particularly in the left insular region, which is activated with sexual arousal, contribute to erectile dysfunction.

Entities:  

Keywords:  Autonomic dysfunction; Erectile dysfunction; Multiple sclerosis; Sexual dysfunction; Voxel-based lesion symptom mapping

Mesh:

Year:  2018        PMID: 29392463     DOI: 10.1007/s00415-018-8763-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

Review 1.  The central autonomic nervous system: conscious visceral perception and autonomic pattern generation.

Authors:  Clifford B Saper
Journal:  Annu Rev Neurosci       Date:  2002-03-25       Impact factor: 12.449

2.  Neuroanatomical correlates of penile erection evoked by photographic stimuli in human males.

Authors:  V Moulier; H Mouras; M Pélégrini-Issac; D Glutron; R Rouxel; B Grandjean; J Bittoun; S Stoléru
Journal:  Neuroimage       Date:  2006-09-07       Impact factor: 6.556

3.  Improving lesion-symptom mapping.

Authors:  Chris Rorden; Hans-Otto Karnath; Leonardo Bonilha
Journal:  J Cogn Neurosci       Date:  2007-07       Impact factor: 3.225

Review 4.  Functional neuroanatomy of autonomic regulation.

Authors:  David F Cechetto; J Kevin Shoemaker
Journal:  Neuroimage       Date:  2009-05-14       Impact factor: 6.556

5.  Age-specific CT and MRI templates for spatial normalization.

Authors:  Christopher Rorden; Leonardo Bonilha; Julius Fridriksson; Benjamin Bender; Hans-Otto Karnath
Journal:  Neuroimage       Date:  2012-03-13       Impact factor: 6.556

6.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis.

Authors:  M A van Walderveen; W Kamphorst; P Scheltens; J H van Waesberghe; R Ravid; J Valk; C H Polman; F Barkhof
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

Review 7.  Multiple sclerosis: the role of MR imaging.

Authors:  Y Ge
Journal:  AJNR Am J Neuroradiol       Date:  2006 Jun-Jul       Impact factor: 3.825

8.  Sexual dysfunction in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psychological correlates.

Authors:  Y Barak; A Achiron; A Elizur; U Gabbay; S Noy; I Sarova-Pinhas
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

9.  Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition.

Authors:  C D Betts; S J Jones; C G Fowler; C J Fowler
Journal:  Brain       Date:  1994-12       Impact factor: 13.501

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  3 in total

1.  Psychobehavioral Treatment Options for Sexual Dysfunction in Multiple Sclerosis: A Systematic Review.

Authors:  Jana Pöttgen; Wim van de Vis; An van Nunen; Anita Rose; Jannie Engelbrecht; Michelle Pirard; Stephanie Lau; Christoph Heesen; Sascha Köpke
Journal:  Int J MS Care       Date:  2020-12-28

2.  Neuroimaging biomarkers of psychogenic erectile dysfunction: protocol for a systematic review.

Authors:  Tao Yin; Zhengjie Li; Jing Xiong; Lei Lan; Ruirui Sun; Feiqiang Ren; Peihai Zhang
Journal:  BMJ Open       Date:  2019-08-26       Impact factor: 2.692

Review 3.  Prevalence of sexual dysfunction in men with multiple sclerosis: a systematic review and meta-analysis.

Authors:  Maryam Dastoorpoor; Maryam Zamanian; Rahmatollah Moradzadeh; Seyed Massood Nabavi; Raana Kousari
Journal:  Syst Rev       Date:  2021-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.